Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Interventional Cardiac Electrophysiology
Metadata
Title
Catheter Ablation of Idiopathic Ventricular Tachycardia: Pathophysiological Insights and Electroanatomical Mapping
Author
Bernd-Dieter Gonska
Publication date
01-06-2001
Publisher
Kluwer Academic Publishers
Published in
Journal of Interventional Cardiac Electrophysiology / Issue 2/2001
Print ISSN: 1383-875X
Electronic ISSN: 1572-8595
DOI
https://doi.org/10.1023/A:1011446012564

Other articles of this Issue 2/2001

Journal of Interventional Cardiac Electrophysiology 2/2001 Go to the issue

OriginalPaper

Catheter Ablation of Idiopathic Left Ventricular Tachycardia with Multiple Breakthrough Sites Guided by an Electroanatomical Mapping System

OriginalPaper

Cardiac Conduction Abnormalities in a Mouse Model of Lyme Borreliosis

OriginalPaper

Entrapment of a Guide Wire by the Chiari Network in a Patient with Ablated Idiopathic Ventricular Tachycardia

OriginalPaper

Prognostic Value of Heart Rate Variability in Time Domain Analysis in Congestive Heart Failure

OriginalPaper

Radiofrequency Catheter Ablation of Posteroseptal Accessory Pathways–Results of a Step-by-Step Ablation Approach

OriginalPaper

P Wave Polarity During Pacing in Pulmonary Veins

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits